Current evidence posits a central role for gut microbiota and the metabolome in the pathogenesis and progression of inflammatory bowel disease (IBD). Fecal microbiota transplantation (FMT) has been established as a means to manipulate this microbiome safely and sustainably. Several aspects of the technical improvement including pretreatment with antibiotics, use of frozen stool samples as well as short donor-to-recipient time are proposed to improve its response rates. Its efficacy in ulcerative colitis has been proven in clinical trials while data is emerging for Crohn’s disease. This review describes briefly the biology behind FMT, the available evidence for its use in IBD, and the host, recipient and procedural factors which determine the clinical outcomes.
Citations
Citations to this article as recorded by
Inflammatory bowel diseases: pathological mechanisms and therapeutic perspectives Xiaona Yang, Hong Guo, Min Zou Molecular Biomedicine.2026;[Epub] CrossRef
Advances in Fecal Microbiota Transplantation for Gut Dysbiosis‐Related Diseases Shuna Hou, Jiachen Yu, Yongshuang Li, Duoyi Zhao, Zhiyu Zhang Advanced Science.2025;[Epub] CrossRef
Gut Microbial Targets in Inflammatory Bowel Disease: Current Position and Future Developments Naveen Sivakumar, Ashwin Krishnamoorthy, Harshita Ryali, Ramesh P. Arasaradnam Biomedicines.2025; 13(3): 716. CrossRef
Medical management of acute severe ulcerative colitis in the hospitalized patient Loren G Rabinowitz, Ajay Gade, Joseph D. Feuerstein Expert Review of Gastroenterology & Hepatology.2025; 19(5): 467. CrossRef
Incidence, Risk Factors, and Outcomes of Chronic Antibiotic-Refractory Pouchitis in Korean Patients with Ulcerative Colitis Ji Eun Baek, Jung-Bin Park, June Hwa Bae, Min Hyun Kim, Seung Wook Hong, Sung Wook Hwang, Jong Lyul Lee, Yong Sik Yoon, Dong-Hoon Yang, Byong Duk Ye, Jeong-Sik Byeon, Seung-Jae Myung, Chang Sik Yu, Suk-Kyun Yang, Sang Hyoung Park Gut and Liver.2025; 19(3): 388. CrossRef
The effect of fecal microbiota transplantation on levels of tryptophan metabolites in intestine and serum of gnotobiotic mice O.P. Shatova, A.V. Shestopalov, E.Yu. Zlatnik, I.A. Novikova, A.S. Goncharova, A.Yu. Maksimov Biomeditsinskaya Khimiya.2025; 71(3): 209. CrossRef
Towards an Asian paradigm of inflammatory bowel disease management: A comparative review of China and Japan Qi Sun, Zhixian Jiang, Lichao Yang, Hao Liu, Peipei Song, Lianwen Yuan Intractable & Rare Diseases Research.2025; 14(3): 192. CrossRef
Fecal microbiota transplantation in mice improves bone material properties through altered mineral quality Bowen Wang, Samuel J Stephen, Erika L Cyphert, Chongshan Liu, Christopher J Hernandez, Deepak Vashishth JBMR Plus.2025;[Epub] CrossRef
Strategic modulation of the gastrointestinal microbiome to enhance pancreatic cancer immunotherapy Satveer Jagwani, Laura Musumeci, Lizbeth Flores, Gerardo G. Mackenzie, Mansoor M. Amiji Drug Discovery Today.2025; 30(12): 104528. CrossRef
‘Mining’ the Gut: The Microbiome ‘Lassonde curve’ HIMANSHU NARANG, VINEET AHUJA The National Medical Journal of India.2025; 38: 257. CrossRef
Molecular links between inflammatory bowel disease and Alzheimer’s disease through immune signaling and inflammatory pathways Siva Sundara Kumar Durairajan, Abhay Kumar Singh, Shahitha M Sulaiman, Supriti Patnaik, Senthilkumar Krishnamoorthi, Ashok Iyaswamy, Balachandar Vellingiri, Chuan-Bin Yang, Leonard L Williams World Journal of Gastroenterology.2025;[Epub] CrossRef
Awareness and perception of fecal microbiota transplantation in Lebanon: a cross-sectional survey among the general population, healthcare workers, physicians, and patients Maysam Shayya, Zeinab Wehbi, Miriam Matar, Mariana Elzein, Zeinab Safieddine, Karen El Khoury, José-Noel Ibrahim, Hussein F. Hassan, Omar Jamal, Rajaa Chatila, Philippe Hussein Kobeissy Therapeutic Advances in Gastroenterology.2025;[Epub] CrossRef
Perception of fecal microbiota transplantation in patients with ulcerative colitis in Korea: a KASID multicenter study Jebyung Park, Sung Noh Hong, Hong Sub Lee, Jongbeom Shin, Eun Hye Oh, Kwangwoo Nam, Gyeol Seong, Hyun Gun Kim, Jin-Oh Kim, Seong Ran Jeon The Korean Journal of Internal Medicine.2024; 39(5): 783. CrossRef
Microbiome-based therapeutics for Parkinson's disease Adam M. Hamilton, Ian N. Krout, Alexandria C. White, Timothy R. Sampson Neurotherapeutics.2024; 21(6): e00462. CrossRef